Quantinno Capital Management LP lifted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 424.3% in the first quarter, Holdings Channel reports. The institutional investor owned 155,086 shares of the real estate investment trust’s stock after buying an additional 125,507 shares during the quarter. Quantinno Capital Management LP’s holdings in Sabra Healthcare REIT were worth $2,982,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Rothschild Investment LLC boosted its stake in Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 889 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares during the period. Strengthening Families & Communities LLC bought a new position in Sabra Healthcare REIT in the fourth quarter worth about $29,000. Danske Bank A S acquired a new position in Sabra Healthcare REIT in the third quarter valued at approximately $30,000. Finally, Larson Financial Group LLC grew its holdings in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 553 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.
Analyst Ratings Changes
SBRA has been the topic of a number of research reports. Truist Financial increased their price target on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Cantor Fitzgerald increased their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Raymond James Financial upgraded Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday. Finally, Wells Fargo & Company boosted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Seven analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $22.25.
Sabra Healthcare REIT Stock Performance
Shares of NASDAQ SBRA opened at $21.04 on Friday. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $22.77. The company has a market cap of $5.37 billion, a PE ratio of 80.93, a P/E/G ratio of 1.63 and a beta of 0.64. The stock has a 50 day simple moving average of $19.82 and a 200-day simple moving average of $19.98. The company has a current ratio of 3.07, a quick ratio of 4.72 and a debt-to-equity ratio of 0.95.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). The business had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm’s revenue was up 24.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 earnings per share. On average, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current year.
Sabra Healthcare REIT Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.7%. The ex-dividend date of this dividend is Friday, August 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 461.54%.
Sabra Healthcare REIT Company Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Recommended Stories
- Five stocks we like better than Sabra Healthcare REIT
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
